Hormonal
Higher visceral adipose tissue (VAT) volume is more strongly associated with adverse metabolic risk factors (hypertension, dyslipidemia, diabetes, metabolic syndrome) than subcutaneous adipose tissue (SAT), and VAT provides significant risk prediction above and beyond standard anthropometric measures like BMI and waist circumference.
If you are concerned about metabolic health, standard weight and waist measurements may not tell the whole story. Visceral fat (fat around organs) is a more dangerous driver of risk than subcutaneous fat (fat under the skin). While you cannot easily measure visceral fat at home, maintaining a healthy weight and active lifestyle helps reduce it. If you have risk factors despite a 'normal' waist, deeper assessment of fat distribution might be relevant.
Although both SAT and VAT are correlated with metabolic risk factors, VAT remains more strongly associated with an adverse metabolic risk profile even after accounting for standard anthropometric indexes. Our findings are consistent with the hypothesized role of visceral fat as a unique, pathogenic fat depot.
Why this rating
Large, community-based sample (n=3001) with rigorous volumetric CT imaging, though cross-sectional design limits causal inference.
Source
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
Caroline S. Fox et al. · Circulation · 2007
DOI 10.1161/circulationaha.106.675355
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →